Intraoperative radiotherapy for breast cancer: powerful evidence to change practice
Nat Rev Clin Oncol
.
2021 Mar;18(3):187-188.
doi: 10.1038/s41571-021-00471-7.
Authors
Jayant S Vaidya
1
,
Max Bulsara
2
3
,
Michael Baum
2
,
Michael Alvarado
4
,
Marcelle Bernstein
5
,
Samuele Massarut
6
,
Christobel Saunders
7
,
Elena Sperk
8
,
Frederik Wenz
9
,
Jeffrey S Tobias
10
;
TARGIT-A investigators
Affiliations
1
Division of Surgery and Interventional Science, University College London, London, UK.
[email protected]
.
2
Division of Surgery and Interventional Science, University College London, London, UK.
3
Department of Biostatistics, University of Notre Dame, Fremantle, WA, Australia.
4
Department of Surgery, University of California, San Francisco, CA, USA.
5
, London, UK.
6
Department of Surgery, Centro di Riferimento Oncologico di Aviano (CRO) IRCCS, Aviano, Italy.
7
School of Surgery, University of Western Australia, Perth, WA, Australia.
8
University Medical Center Mannheim, Medical Faculty Mannheim, Heidelberg University, Heidelberg, Germany.
9
University Medical Center Freiburg, Freiburg, Germany.
10
Department of Clinical Oncology, University College London Hospitals, London, UK.
PMID:
33495552
PMCID:
PMC7830040
DOI:
10.1038/s41571-021-00471-7
No abstract available
Publication types
Letter
Research Support, Non-U.S. Gov't
Kommentar
MeSH terms
Breast Neoplasms* / radiotherapy
Breast Neoplasms* / surgery
Humans
Mastectomy, Segmental*
Neoplasm Recurrence, Local
Radiotherapy, Adjuvant
Grants and funding
10/104/07/DH_/Department of Health/United Kingdom
14/49/13/DH_/Department of Health/United Kingdom
HTA 07/60/49/DH_/Department of Health/United Kingdom